Prospera Financial Services’s Hepion Pharmaceuticals HEPA Stock Holding History

Prospera Financial Services’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8	Closed	-$10K	–	2041
2022 Q1	$10K	Buy	+8	New	+$8.84K	﹤0.01%	2034
2021 Q4	–	Sell	-30	Closed	-$46K	–	883
2021 Q3	$46K	Hold	30	–	–	﹤0.01%	788
2021 Q2	$60K	Sell	30 -1	-3%	-$1.83K	﹤0.01%	782
2021 Q1	$58K	Sell	31 -8	-21%	-$17.5K	﹤0.01%	736
2020 Q4	$86K	Buy	+39	New	+$101K	0.01%	663
2020 Q3	–	Sell	-34	Closed	-$97K	–	1646
2020 Q2	$97K	Sell	34 -1	-3%	-$1.91K	0.01%	561
2020 Q1	$62K	Buy	35 +22	+169%	+$87.9K	0.01%	502
2019 Q4	$70K	Buy	+13	New	+$50.3K	0.01%	587
2019 Q2	–	Hold	0	–	-$4K	–	522
2019 Q1	–	Hold	0	–	–	–	321
2018 Q3	–	Hold	0	–	-$26K	–	427
2018 Q2	–	Hold	0	–	–	–	446
2018 Q1	–	Hold	0	–	–	–	436
2017 Q4	–	Hold	0	–	–	–	387
2017 Q3	–	Hold	0	–	–	–	411
2017 Q2	–	Hold	0	–	–	–	410
2017 Q1	–	Hold	0	–	–	–	274
2016 Q4	–	Hold	0	–	–	–	315
2016 Q3	–	Hold	0	–	–	–	345
2016 Q2	–	Hold	0	–	–	–	326
2016 Q1	–	Hold	0	–	–	–	288
2015 Q4	–	Hold	0	–	–	–	279
2015 Q3	–	Hold	0	–	–	–	265
2015 Q2	–	Hold	0	–	–	–	293

Other funds holding HEPA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return

Prospera Financial Services's HEPA Position: Q2 2022 in Review

Prospera Financial Services sold out of Hepion Pharmaceuticals (HEPA) in Q2 2022, closing a stake of 8 shares — an estimated $10K sold.

Prospera Financial Services first reported a position in HEPA in Q4 2019 and held it in 8 quarters. The position peaked at $97K in Q2 2020. 28 funds tracked by Wall St. Rank hold HEPA as of Q2 2022.

Prospera Financial Services reported no remaining Hepion Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Prospera Financial Services sold 8 Hepion Pharmaceuticals shares in Q2 2022, an estimated $10K.
Prospera Financial Services first reported a position in Hepion Pharmaceuticals in Q4 2019 and held it in 8 quarters.
Prospera Financial Services's Hepion Pharmaceuticals position peaked at $97K in Q2 2020.
28 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.